Alternate Day Buprenorphine Administration, Phase IX - 14

Completed · Phase 2

Conditions studied: Opioid-Related Disorders

In brief

The purpose of this study is to determine if four times a subjects' daily maintenance dose will hold for 120 hours without changes in agonist and antagonist effects.

Key facts

Study ID

NCT00000232

Run by

University of Vermont

People needed

0

Starts

1992-03-01

Last updated by the study team

2016-05-06

Who can join

Age: 22 and older, up to 51. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Treatment Research Center — Burlington, Vermont, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.